Search
GSK congratulates ten of its doctoral students who have been recognized by esteemed organizations for their promising academic research.
Learn about a blood test using carbon nanotubes that could potentially detect brain tumors.
Learn about how the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center supports MSK researchers as they learn more about the number one problem in cancer research today.
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
Learn more about olaratumab, a promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma — particularly leiomyosarcoma — by nearly a year in a phase II clinical trial.
Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Read about the 26th annual bone marrow transplant (BMT) Thrivers event, which took place on November 17, 2021.
Third-year students Nicholas Gauthier and Karen Hunter have been named the first Grayer Fellows at Gerstner Sloan Kettering.
Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.